Skip to main content

Lydia Dux-Santoy Hurtado

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Lydia Dux-Santoy Hurtado

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Aneurisma aterosclerótico de aorta torácica descendente y abdominal: predictores biomecánicos, histológicos y hemodinámicos de dilatación aórtica y eventos adversos

IP: Jose Fernando Rodríguez Palomares
Collaborators: Sergi Bellmunt Montoya, Aroa Ruiz Muñoz, Lydia Dux-Santoy Hurtado, Ruperto Olivero Soldevila
Funding agency: Instituto de Salud Carlos III
Funding: 127050
Reference: PI19/01480
Duration: 01/01/2020 - 30/06/2024

CardioP3T: Nuevos biomarcadores de diagnóstico y pronóstico en patología cardíaca a partir de técnicas de imagen híbrida PET-RM

IP: Jose Fernando Rodríguez Palomares
Collaborators: Lydia Dux-Santoy Hurtado, Andrea Guala
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 138065.8
Reference: RTC2019-007280-1
Duration: 01/01/2020 - 31/12/2023

Ministerio de Ciencia

ANEURISMAS DE AORTA ASCENDENTE. PROGRESION DE LA DILATACION: ETIOPATOGENIA Y NUEVOS BIOMARCADORES DE IMAGEN PARA PREDECIR SU EVOLUCION

IP: -
Collaborators: Jose Fernando Rodríguez Palomares, Rafael Rodríguez Lecoq, Gisela Teixido Tura, Aroa Ruiz Muñoz, Hug Cuellar Calabria, Lydia Dux-Santoy Hurtado, Andrea Guala
Funding agency: Instituto de Salud Carlos III
Funding: 134310
Reference: PI17/00381
Duration: 01/01/2018 - 30/06/2022

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Josep Majo Llopart

Josep Majo Llopart

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Tatiana Murillo Fontana

Tatiana Murillo Fontana

Read more
Clara Serra Juhe

Clara Serra Juhe

Postdoctoral researcher
Genetics Medicine
Read more
Jose Alemañ Diez

Jose Alemañ Diez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.